|1.||Schaefer, E: 2 articles (03/2011 - 06/2006)|
|2.||Tytgat, Guido N: 2 articles (11/2008 - 01/2007)|
|3.||Boone, Darren: 1 article (12/2015)|
|4.||Burling, David: 1 article (12/2015)|
|5.||East, James E: 1 article (12/2015)|
|6.||Halligan, Steve: 1 article (12/2015)|
|7.||Saunders, Brian P: 1 article (12/2015)|
|8.||Taylor, Stuart A: 1 article (12/2015)|
|9.||Tam, Emily: 1 article (12/2015)|
|10.||Park, Hyeong Chun: 1 article (11/2015)|
01/01/2009 - "Multiple cutaneous leiomyomas: pain relief with pulsed hysocine butyl bromide."
11/01/2014 - "For several years, we have therefore been asking general practitioners to consider teaching such patients to administer intramuscular hyoscine butylbromide for pain episodes and this study is an audit of this approach. "
01/01/2007 - "This article reviews the pharmacology and pharmacokinetic profile of hyoscine butylbromide, and summarises efficacy and safety data from clinical trials of this drug for abdominal cramping and pain. "
08/01/2013 - "Hyoscine butylbromide is - when available - the preferred spasmolytic agent because of the positive effect on insufflation and pain/burden and its low costs. "
05/01/2008 - "Intravenous Hyoscine N-Butyl Bromide causes pain relief of up to 36% and shortens the duration of active phase without any untoward short term fetal or maternal effects."
|2.||Abdominal Pain (Pain, Abdominal)
01/01/2007 - "Hyoscine butylbromide was considered beneficial in all of these trials, which supports its use in the treatment of abdominal pain caused by cramping. "
11/01/2014 - "The use of intramuscular hyoscine butylbromide shows promise in the management of IBS when severe unmanageable abdominal pain is a major problem. "
08/01/2013 - "Hyoscine butylbromide (HBB) has been used for 60 years to treat cramping abdominal pain, but scientific evidence to support on-demand use is limited. "
08/01/2013 - "On-demand hyoscine butylbromide for the treatment of self-reported functional cramping abdominal pain."
01/01/2007 - "In summary, hyoscine butylbromide appears to be a valuable treatment option for patients with symptoms of abdominal pain or discomfort associated with cramping."
01/01/2010 - "In a prospective, randomized, double-blind study design, muscle spasm was recorded during insertion and withdrawal during routine colonoscopy, and the number of polyps detected were compared between two groups of 58 patients characterized with either hyosine N-butyl bromide (Hyosine group) or placebo (Placebo group) injected at reaching the cecum. "
11/01/2008 - "Hyoscine butylbromide - a review on its parenteral use in acute abdominal spasm and as an aid in abdominal diagnostic and therapeutic procedures."
09/01/2008 - "Thirty-nine patients received intraoperative hyoscine butylbromide to reduce bladder spasm. "
05/01/2008 - "Hyoscine N-butyl bromide (HBB) acts by inhibiting cholinergic transmission in the abdomino-pelvic parasympathetic ganglia, thus relieving spasm in the smooth muscles of gastrointestinal, biliary, urinary tract and female genital organs, especially the cervico-uterine plexus and aiding cervical dilatation. "
03/01/2011 - "Hyoscine butylbromide is effective in the treatment of recurrent gastric or intestinal spasm-like pain and well tolerated. "
06/14/2014 - "Four RCTs included 1882 patients, of whom 948 received hyoscine butylbromide, and the adenoma detection rate was reported. "
12/01/2015 - "IV hyoscine butylbromide at simulated colonoscope withdrawal was associated with significant increases in surface visualization, which might explain up to half the improvement in adenoma detection seen in clinical studies."
12/01/2015 - "Mechanisms of hyoscine butylbromide to improve adenoma detection: A case-control study of surface visualization at simulated colonoscope withdrawal."
04/30/2015 - "Subjective hypersalivation was not improved, but objective hypersalivation was, by scopolamine butylbromide treatment. "
04/30/2015 - "As a result, improvements in the patients' Drooling Severity Scale and Drooling Frequency Scale scores, but no improvements in their visual analog scale scores, were observed after scopolamine butylbromide treatment. "
04/30/2015 - "This study investigated the efficacy of the anticholinergic agent scopolamine butylbromide against clozapine-induced hypersalivation. "
04/30/2015 - "These results indicate that at least some schizophrenic patients with clozapine-induced hypersalivation would benefit from scopolamine butylbromide treatment. "
04/30/2015 - "Effect of Scopolamine Butylbromide on Clozapine-induced Hypersalivation in Schizophrenic Patients: A Case Series."
|6.||Tetraethylammonium (Tetraethylammonium Bromide)
|7.||Hexamethonium (Hexamethonium Bromide)
|8.||Succinylcholine (Suxamethonium Chloride)